CA2338604A1 - A bag or a bag system for collecting and storing blood and a method therefor - Google Patents
A bag or a bag system for collecting and storing blood and a method therefor Download PDFInfo
- Publication number
- CA2338604A1 CA2338604A1 CA002338604A CA2338604A CA2338604A1 CA 2338604 A1 CA2338604 A1 CA 2338604A1 CA 002338604 A CA002338604 A CA 002338604A CA 2338604 A CA2338604 A CA 2338604A CA 2338604 A1 CA2338604 A1 CA 2338604A1
- Authority
- CA
- Canada
- Prior art keywords
- bag
- storage chambers
- blood
- bag system
- primary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 109
- 239000008280 blood Substances 0.000 title claims abstract description 109
- 238000000034 method Methods 0.000 title claims abstract description 13
- 238000003860 storage Methods 0.000 claims abstract description 111
- 238000002156 mixing Methods 0.000 claims description 70
- 238000003466 welding Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 16
- 238000004891 communication Methods 0.000 claims description 10
- 210000002826 placenta Anatomy 0.000 claims description 9
- 239000003755 preservative agent Substances 0.000 claims description 8
- 239000003146 anticoagulant agent Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 210000003954 umbilical cord Anatomy 0.000 claims description 7
- 238000007599 discharging Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 4
- 210000004700 fetal blood Anatomy 0.000 claims description 4
- 239000004417 polycarbonate Substances 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 claims description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 2
- 239000004642 Polyimide Substances 0.000 claims description 2
- 230000010100 anticoagulation Effects 0.000 claims description 2
- 238000005138 cryopreservation Methods 0.000 claims description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- -1 polyethylene, ethylene vinyl acetate Polymers 0.000 claims description 2
- 229920001721 polyimide Polymers 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 108091006146 Channels Proteins 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 3
- 210000000130 stem cell Anatomy 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 101100234002 Drosophila melanogaster Shal gene Proteins 0.000 description 1
- 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 235000015076 Shorea robusta Nutrition 0.000 description 1
- 244000166071 Shorea robusta Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
- A61M1/0236—Multiple bag systems for separating or storing blood components with sampling means, e.g. sample bag or sampling port
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
- A61J1/12—Bag-type containers with means for holding samples of contents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- External Artificial Organs (AREA)
Abstract
The present invention relates to a bag or a bag system for collecting and storing blood comprising at least two primary storage chambers and at least two secondary storage chambers, arranged in such a relation to each other so that each of the storage chambers can be sealed off from the others, and a method for collecting and storing blood.
Description
14 fl7 2flfJfl ~~ i lt'7~C991QL~4~2 ' p~SC
WO 00/06079 , , , , .. . ~ ~ ~ ~ ~ . . ~ Y .t.
C ~4h9~~G~~_ 1 . . . . . . . ..
.... » . . . . . . .
..
... . .. . .. ..
A bag or a bag system for collecting and storing blood and a method therefor The present invention relates to a bag or a bag system for collecting and storing blood and a method for col lecting and storing blood.
It is well mown to extract blood from human beings and store this blood in a frozen or refrigerated condition for later use during operations, blood transfusions, and the like. For this purpose a number of different blood bags have been provided.
In the past few years it has become known that blood from the umbilical cord and the placenta at birth contains stem cells, cells that are only present in the blood at this specific time of a person's life. These cells have shown a considerable potential curative value, e.g. for use in bone marrow replacement procedures in cancer treatment and other immunodeficiencv disorders.
In order to preserve these cells, blood from the umbili-cal cord and/or the placenta, which would otherwise just have been discarded, has been collected and stored at low temperatures. The containers used in this procedure are known to be conventional blood bags, as those mentioned above_ However, in order to ta~~e a sample from a bag with frozen blood, it is necessary to defrost the entire amount of blood, and once defrosted it must either be used shortly after or discarded, since it is not refreezable. The problem regarding the conventional bags and methods is therefore that the chance of using the stem cells to cure a patient is limited to only once.
~~ 5e a ~~ ~l a:.
AMENDED SHEET;
R~'~~"~t~~ ~CA 02338604 2001-O1-25 '~1t 14 ~ ~ ?fl(~fl ~~T1~~9~14fl~:22 .. . . . . .. . .
:: .: .: : . . . . . . , . . . . . . . . . . .. , .... . . . . . . . .
. . . . . . . ..
... . .. . .. ..
la EP 0 790 051 ~:2 discloses a flexible plastic container.
The container has at least four compartments. Each compartment has its own inlet opening. An outlet feeds the liquids into the body into the intestines or via any other way. The compartments can be interconnected by valves, which can be opened from the outside. By selectively opening these valves, liquids in the compartments may be completely mixed.
AMENDED SHEE'~, ~~"~~~~ CA 02338604 2001-O1-25 JP 10000229A discloses a bag system for isolating stem cells and precursor cells from umbilical cord blood by centrifugation. This system consisting of 6 bags equipped .
with connectors and tubes to lead the blood from bag to S bag, comprises one bag wherein the obtained leucocyte , component containing the above mentioned cells are fro-zen. The problem relating to this bag is, however, the same, as it is not possible to defrost part of the cells without destroying the rest.
It is therefore the object of the present invention to provide a solution to the problem defined above, and in '-particular to provide a bag or a bag system for collect-ing and storing blood, in particular umbilical cord blood and/or blood from the placenta, designed to make it pos sible to defrost only a part of the stored blood.
The invention relates to a bag or a bag system for col-lecting and storing blood as defined in claim l, a bag or a bag system for collecting and storing blood in combina-tion with a mixing bag as defined in. claim 4, and a bag or a bag system for collecting, mixing, and storing blood as defined in claim 5. ,.
A bag or a bag system according to the present invention may contain a system of storage chambers alone, equipped only with an opening for receiving blood, or the opening for receiving blood may comprise an inlet channel. This inlet channel can be a small tube suitable to be con-nected to a mixing chamber adapted with e.g. a snap lock, a clamp or a similar easy operational closing device.
Another aspect of the invention is a bag or a bag system for collecting and storing blood in combination with a mixing bag, where the mixing bag comprises at least one mixing chamber, an opening for receiving blood and an opening for discharging blood. Regarding the mixing bag, the opening for receiving blood and the opening for dis-charging blood may be the same. 'flue opening for discharg-ing blood is adapted to be connected to the opening for receiving blood in the bag or the bag system for collect-ing and storing blood, e.g. by use of suitable connec-tors.
A further aspect of the invention is a bag or a bag sys-tem for collecting and storing blood comprising a mixing chamber, where said mixing chamber can be sealed off from the storage chambers by closing e.g. a snap loci: or by using a clamp or by welding. In order to minimise the amount of equipment to be stored, it is preferred that the mixing chamber is arranged in such a relation to the storage chambers so that it can be ~>ealed off therefrom and removed before storage.
A mixing chamber of a bag or a bag system according to o-the invention should have a volume which corresponds to or is bigger than the sum of the volumes of the primary and secondary storage chambers. In order to use the mix-ing chamber for mixing the blood with anticoagulation agent and/or preserving agent, the mixing bag should preferably have a volume at least twi~~e as big as the sum of tine volumes of the primary and secondary storage cham-bers. The mixing chamber may a.g. h<~ve a volume in the range of 100 to 500 ml, preferably ;?25 to 900 ml, more preferably 250 to 300 mI. In a preferred embodiment the mixing chamber may e.g. have a volume in the range of 100 to 500 ml, preferably 125 to 900 ml, more preferably 150 to 250 ml.
The mixing chamber may further comprise at least one port for injection of anticoagulation and/or preserving agents WO 00/06079 PC'T/DK99/00422 and/or at least one port for extracting blood in order to perform tests, e.g. to detect contamination by vira.
In all of the above mentioned bags the primary and secon-dary chambers are in liquid coaTUnunication witin each other. This liquid communication may preferably be pro vided by pipe connections with a length in the range of 10-20 mm, preferably 12-15 mm. In another embodiment the pipe connections has a length in the range of 10-300 mm, preferably about 100 mm.
The inner diameter of said pipe connections may be in the 'v range of 2-10 mm, preferably 3-8 mm, more preferably 9-6 mm when the pipes are in a non collapsed condition.
During the process of sealing off each of the storage chambers, e.g. by welding (heat welding, impulse weldincJ
or other) or by closing a snap lock or a clamp, prefera bly shortly after the filling is completed, it is impor o tant to ensure that only a minimal air,ount of the obtained blood is destroyed. The bag or the bag system according to the invention, which is provided with the above men-tioned pipe connections containing only a minimum of blood, ensures that only a very small percentage of the total amount of blood is damaged in connection with the closing of these channels by e.g. heat.
By using a bag or a bag system according to the present invention for storing umbilical cord bl_oed it is possible to obtain at least two, preferably at least 5 primary storage chambers, more preferably at least 8 primary storage chambers, and most preferably at least 10 primary storage chambers, all containing blood. Of course the number of chambers filled with blood depends on how much blood it is possible to extract froru the umbilical cord and the placenta as well as how the blood bag is de-signed.
The volume of the primary storage chambers is usually in 5 the range of 10 to 40 ml, preferably 25 to 35 ml, more preferably 25 to 30 ml. In a another embodiment the vol-ume of the primary storage chambers i'> in the range of 10 to 80 ml, preferably 25 to 70 ml, more preferably 25 to 50 ml.
It is however preferred to obtain as many storage cham-bers as possible, since this provides the patient with the largest flexibility in using the stored blood. Since any number of chambers filled with blood can be removed from the bag, i t is possible to defrost only the amount of blood needed far the intended treatment.
The system of chambers also comprises a number of secon dary storage chambers, preferably equal to at least the a number of primary storage chambers, all of which may be sealed off and removed individually as the primary cham-bers. The object of these secondary chambers is to pro-vide small amounts of blood for test purposes. Therefore the ratio between the volumes of the primary and secon-dary storage chambers is preferably between 40:1 and 60:1, more preferably about 50:1. In another embodiment the ratio between the volumes of the primary and secon-dary storage chamber is in between 90:1 and 150:1, pref-erably between 50:1 and 80:1.
having secondary storage chambers with a volume in the range of 0, 2 to l, S ml, preferably 0, 3 to 0, 7 ml, more preferably 0,4 to 0,6 ml, eliminates the need for de-frosting more than one cr two secondary storage chambers to obtain the necessary amount, e.g. 0,5 ml, of blood in order to test it and see if it is suitable for the in-WO 00/06079 PC'T/DK99/00422 tended use. This particular feature is of great impor-tance, since it is essential to determine the guality of the blood in order to find out the right amount of blood needed for the treatment, to check Cor contamination of the blood (e. g. bacteria) or to perform a gene test.
In a preferred embodiment all the primary storage cham-bers are marked or adapted to be marked individually, each with at least one corresponding secondary storage chamber. Further, the bag or the bag system itself is preferably marked or adapted to be marked with a date and/or a number in order to be able to identify the bag.
The primary storage chambers can have various shapes, preferrea embodiments, however, are those where the shape is substantially rectangular or subst=antially round when the bag or the bag system is in a collapsed condition.
Since long term storage of blood typically includes Bub-o-jecting the bag or the bag system to temperatures below -170 °C, it is very important that the bag or the bag sys-tem is made of a suitable material, e.g. a material of medical or pharmaceutical grade. Lxamples of suitable ma-terials are e.g. a polyethylen, an ethylene vinyl acetate 'J
copolymer, a fluorine resin, a polyimide, silicone, an ABS polymer (acrylonitrile/butadien/styrene polymer) or a polycarbonate.
The bag or the bag system may consist of one or more fo-lio layers, e.g. joined by welding, and in cases regard-ing more than one folio layer, the mai=erial of the layers may be selected among the above-mentioned materials and may be identical or different.
In a preferred e~c~bodiment according to tine invention, the bag system comprises primary and secc>ndary storage cham-tiers made of one of the above mentioned materials, said bag system being arranged or being able to be arranged in a second bag e.c~. surrounding flue ba<1 system by the sec-ond bag made of a suitable material. The second bag may be divided into a number of compartments.
The invention also relates to a method for collecting and storing umbilical cord blood and/or blood from a pla-centa, comprising the steps of:
a) extracting blood from the umbilica l cord and/or the placenta, b) leading it into a mixing chamber, ~e.g. by injection, c) mixing the blood with a preserving agent and/or an an-ticoagulation agent, d) optionally storing it for no longer than 29 hours, o-e) optionally adding further chemicals to prepare the blood for cryo-preservation, f) providing a liquid communication between the mixing chamber and a number of storage chambers, allowing the blood mixture to flow into said storage chambers, g) closing the bag or the bag system witt: a clamp and op-tionally removing the mixing chamber, h) closing the channels between the various chambers e.g.
by welding or by closing a snap loch or a clamp, thereby providing a number of primary and secondary storage cham-bers sealed off from each other, and i) immediately placing the bag or the bag system in a freezer bringing the temperature below about -70 °C, wherein said primary and said secondary storage chambers are arranged in a bag or a bag system wherein the chan-nels are linked to each other with intermediate seals, and the volume of the primary storage chambers is larger than the volume of the secondary stor<3ge chambers.
It should be observed that step e)-i) may be carried out after storing the blood for no longer than 29 hours under conditions with no bacteria growth, e.g. in a refrigera-tor.
The extracting of blood from an umbilical cord and lead-ing it into a mixing chamber may be done in any conven-tional way. Preferably the extracting should be done in a way accepted by those skilled in the art.
The anticoagulation agent and/or the preserving agent may be added after the blood has been l.ed into the mixing chamber, however, it is preferred that they are already present in the chamber at the time the blcod is led, which simplifies the method, since the mixing chambers can be prepared for use in advance.
However, in special cases where the amount of extracted blood is small it may be preferred to add the anticoagu-lation agent and/or the preserving agent after the col-lecting of the blood, in order to ensure that t=he ratio between the blood and the above ment=Toned agents is in the best possible range. Therefore, in a preferred em-bodiment, the mixing chamber is provided with at least one extra port to facilitate the addition of anticoagula-tion agent and/or preserving agent.
WO 00/06079 , , , , .. . ~ ~ ~ ~ ~ . . ~ Y .t.
C ~4h9~~G~~_ 1 . . . . . . . ..
.... » . . . . . . .
..
... . .. . .. ..
A bag or a bag system for collecting and storing blood and a method therefor The present invention relates to a bag or a bag system for collecting and storing blood and a method for col lecting and storing blood.
It is well mown to extract blood from human beings and store this blood in a frozen or refrigerated condition for later use during operations, blood transfusions, and the like. For this purpose a number of different blood bags have been provided.
In the past few years it has become known that blood from the umbilical cord and the placenta at birth contains stem cells, cells that are only present in the blood at this specific time of a person's life. These cells have shown a considerable potential curative value, e.g. for use in bone marrow replacement procedures in cancer treatment and other immunodeficiencv disorders.
In order to preserve these cells, blood from the umbili-cal cord and/or the placenta, which would otherwise just have been discarded, has been collected and stored at low temperatures. The containers used in this procedure are known to be conventional blood bags, as those mentioned above_ However, in order to ta~~e a sample from a bag with frozen blood, it is necessary to defrost the entire amount of blood, and once defrosted it must either be used shortly after or discarded, since it is not refreezable. The problem regarding the conventional bags and methods is therefore that the chance of using the stem cells to cure a patient is limited to only once.
~~ 5e a ~~ ~l a:.
AMENDED SHEET;
R~'~~"~t~~ ~CA 02338604 2001-O1-25 '~1t 14 ~ ~ ?fl(~fl ~~T1~~9~14fl~:22 .. . . . . .. . .
:: .: .: : . . . . . . , . . . . . . . . . . .. , .... . . . . . . . .
. . . . . . . ..
... . .. . .. ..
la EP 0 790 051 ~:2 discloses a flexible plastic container.
The container has at least four compartments. Each compartment has its own inlet opening. An outlet feeds the liquids into the body into the intestines or via any other way. The compartments can be interconnected by valves, which can be opened from the outside. By selectively opening these valves, liquids in the compartments may be completely mixed.
AMENDED SHEE'~, ~~"~~~~ CA 02338604 2001-O1-25 JP 10000229A discloses a bag system for isolating stem cells and precursor cells from umbilical cord blood by centrifugation. This system consisting of 6 bags equipped .
with connectors and tubes to lead the blood from bag to S bag, comprises one bag wherein the obtained leucocyte , component containing the above mentioned cells are fro-zen. The problem relating to this bag is, however, the same, as it is not possible to defrost part of the cells without destroying the rest.
It is therefore the object of the present invention to provide a solution to the problem defined above, and in '-particular to provide a bag or a bag system for collect-ing and storing blood, in particular umbilical cord blood and/or blood from the placenta, designed to make it pos sible to defrost only a part of the stored blood.
The invention relates to a bag or a bag system for col-lecting and storing blood as defined in claim l, a bag or a bag system for collecting and storing blood in combina-tion with a mixing bag as defined in. claim 4, and a bag or a bag system for collecting, mixing, and storing blood as defined in claim 5. ,.
A bag or a bag system according to the present invention may contain a system of storage chambers alone, equipped only with an opening for receiving blood, or the opening for receiving blood may comprise an inlet channel. This inlet channel can be a small tube suitable to be con-nected to a mixing chamber adapted with e.g. a snap lock, a clamp or a similar easy operational closing device.
Another aspect of the invention is a bag or a bag system for collecting and storing blood in combination with a mixing bag, where the mixing bag comprises at least one mixing chamber, an opening for receiving blood and an opening for discharging blood. Regarding the mixing bag, the opening for receiving blood and the opening for dis-charging blood may be the same. 'flue opening for discharg-ing blood is adapted to be connected to the opening for receiving blood in the bag or the bag system for collect-ing and storing blood, e.g. by use of suitable connec-tors.
A further aspect of the invention is a bag or a bag sys-tem for collecting and storing blood comprising a mixing chamber, where said mixing chamber can be sealed off from the storage chambers by closing e.g. a snap loci: or by using a clamp or by welding. In order to minimise the amount of equipment to be stored, it is preferred that the mixing chamber is arranged in such a relation to the storage chambers so that it can be ~>ealed off therefrom and removed before storage.
A mixing chamber of a bag or a bag system according to o-the invention should have a volume which corresponds to or is bigger than the sum of the volumes of the primary and secondary storage chambers. In order to use the mix-ing chamber for mixing the blood with anticoagulation agent and/or preserving agent, the mixing bag should preferably have a volume at least twi~~e as big as the sum of tine volumes of the primary and secondary storage cham-bers. The mixing chamber may a.g. h<~ve a volume in the range of 100 to 500 ml, preferably ;?25 to 900 ml, more preferably 250 to 300 mI. In a preferred embodiment the mixing chamber may e.g. have a volume in the range of 100 to 500 ml, preferably 125 to 900 ml, more preferably 150 to 250 ml.
The mixing chamber may further comprise at least one port for injection of anticoagulation and/or preserving agents WO 00/06079 PC'T/DK99/00422 and/or at least one port for extracting blood in order to perform tests, e.g. to detect contamination by vira.
In all of the above mentioned bags the primary and secon-dary chambers are in liquid coaTUnunication witin each other. This liquid communication may preferably be pro vided by pipe connections with a length in the range of 10-20 mm, preferably 12-15 mm. In another embodiment the pipe connections has a length in the range of 10-300 mm, preferably about 100 mm.
The inner diameter of said pipe connections may be in the 'v range of 2-10 mm, preferably 3-8 mm, more preferably 9-6 mm when the pipes are in a non collapsed condition.
During the process of sealing off each of the storage chambers, e.g. by welding (heat welding, impulse weldincJ
or other) or by closing a snap lock or a clamp, prefera bly shortly after the filling is completed, it is impor o tant to ensure that only a minimal air,ount of the obtained blood is destroyed. The bag or the bag system according to the invention, which is provided with the above men-tioned pipe connections containing only a minimum of blood, ensures that only a very small percentage of the total amount of blood is damaged in connection with the closing of these channels by e.g. heat.
By using a bag or a bag system according to the present invention for storing umbilical cord bl_oed it is possible to obtain at least two, preferably at least 5 primary storage chambers, more preferably at least 8 primary storage chambers, and most preferably at least 10 primary storage chambers, all containing blood. Of course the number of chambers filled with blood depends on how much blood it is possible to extract froru the umbilical cord and the placenta as well as how the blood bag is de-signed.
The volume of the primary storage chambers is usually in 5 the range of 10 to 40 ml, preferably 25 to 35 ml, more preferably 25 to 30 ml. In a another embodiment the vol-ume of the primary storage chambers i'> in the range of 10 to 80 ml, preferably 25 to 70 ml, more preferably 25 to 50 ml.
It is however preferred to obtain as many storage cham-bers as possible, since this provides the patient with the largest flexibility in using the stored blood. Since any number of chambers filled with blood can be removed from the bag, i t is possible to defrost only the amount of blood needed far the intended treatment.
The system of chambers also comprises a number of secon dary storage chambers, preferably equal to at least the a number of primary storage chambers, all of which may be sealed off and removed individually as the primary cham-bers. The object of these secondary chambers is to pro-vide small amounts of blood for test purposes. Therefore the ratio between the volumes of the primary and secon-dary storage chambers is preferably between 40:1 and 60:1, more preferably about 50:1. In another embodiment the ratio between the volumes of the primary and secon-dary storage chamber is in between 90:1 and 150:1, pref-erably between 50:1 and 80:1.
having secondary storage chambers with a volume in the range of 0, 2 to l, S ml, preferably 0, 3 to 0, 7 ml, more preferably 0,4 to 0,6 ml, eliminates the need for de-frosting more than one cr two secondary storage chambers to obtain the necessary amount, e.g. 0,5 ml, of blood in order to test it and see if it is suitable for the in-WO 00/06079 PC'T/DK99/00422 tended use. This particular feature is of great impor-tance, since it is essential to determine the guality of the blood in order to find out the right amount of blood needed for the treatment, to check Cor contamination of the blood (e. g. bacteria) or to perform a gene test.
In a preferred embodiment all the primary storage cham-bers are marked or adapted to be marked individually, each with at least one corresponding secondary storage chamber. Further, the bag or the bag system itself is preferably marked or adapted to be marked with a date and/or a number in order to be able to identify the bag.
The primary storage chambers can have various shapes, preferrea embodiments, however, are those where the shape is substantially rectangular or subst=antially round when the bag or the bag system is in a collapsed condition.
Since long term storage of blood typically includes Bub-o-jecting the bag or the bag system to temperatures below -170 °C, it is very important that the bag or the bag sys-tem is made of a suitable material, e.g. a material of medical or pharmaceutical grade. Lxamples of suitable ma-terials are e.g. a polyethylen, an ethylene vinyl acetate 'J
copolymer, a fluorine resin, a polyimide, silicone, an ABS polymer (acrylonitrile/butadien/styrene polymer) or a polycarbonate.
The bag or the bag system may consist of one or more fo-lio layers, e.g. joined by welding, and in cases regard-ing more than one folio layer, the mai=erial of the layers may be selected among the above-mentioned materials and may be identical or different.
In a preferred e~c~bodiment according to tine invention, the bag system comprises primary and secc>ndary storage cham-tiers made of one of the above mentioned materials, said bag system being arranged or being able to be arranged in a second bag e.c~. surrounding flue ba<1 system by the sec-ond bag made of a suitable material. The second bag may be divided into a number of compartments.
The invention also relates to a method for collecting and storing umbilical cord blood and/or blood from a pla-centa, comprising the steps of:
a) extracting blood from the umbilica l cord and/or the placenta, b) leading it into a mixing chamber, ~e.g. by injection, c) mixing the blood with a preserving agent and/or an an-ticoagulation agent, d) optionally storing it for no longer than 29 hours, o-e) optionally adding further chemicals to prepare the blood for cryo-preservation, f) providing a liquid communication between the mixing chamber and a number of storage chambers, allowing the blood mixture to flow into said storage chambers, g) closing the bag or the bag system witt: a clamp and op-tionally removing the mixing chamber, h) closing the channels between the various chambers e.g.
by welding or by closing a snap loch or a clamp, thereby providing a number of primary and secondary storage cham-bers sealed off from each other, and i) immediately placing the bag or the bag system in a freezer bringing the temperature below about -70 °C, wherein said primary and said secondary storage chambers are arranged in a bag or a bag system wherein the chan-nels are linked to each other with intermediate seals, and the volume of the primary storage chambers is larger than the volume of the secondary stor<3ge chambers.
It should be observed that step e)-i) may be carried out after storing the blood for no longer than 29 hours under conditions with no bacteria growth, e.g. in a refrigera-tor.
The extracting of blood from an umbilical cord and lead-ing it into a mixing chamber may be done in any conven-tional way. Preferably the extracting should be done in a way accepted by those skilled in the art.
The anticoagulation agent and/or the preserving agent may be added after the blood has been l.ed into the mixing chamber, however, it is preferred that they are already present in the chamber at the time the blcod is led, which simplifies the method, since the mixing chambers can be prepared for use in advance.
However, in special cases where the amount of extracted blood is small it may be preferred to add the anticoagu-lation agent and/or the preserving agent after the col-lecting of the blood, in order to ensure that t=he ratio between the blood and the above ment=Toned agents is in the best possible range. Therefore, in a preferred em-bodiment, the mixing chamber is provided with at least one extra port to facilitate the addition of anticoagula-tion agent and/or preserving agent.
After mixing the blood with the above mentioned agents, the mixing chamber is brought into liquid communication with the storage chambers of the bag or the bag system according to the invention. Depending on which type of bag is being used, the connection can be made by use of tubes and connectors, or in a preferred embodiment of the invention simply by opening a snap lock between the mix-ing chamber and the storage chambers.
This allows the blood to flow into the primary and secon-dary storage chambers, and after filling of as many cham-bers as possible with blood, the opening for receiving blood is closed, e.g. by use of a clamp er a snap lock.
Since there is no reed to store the attached empty mixing chamber, it is preferred to remove the mixing chamber, e.g. by cutting it of or removing the tubes and connec-tors that have been used.
o-In order to obtain a number of chambers that can be re-moved individually, the liquid conununication bet=ween the chambers has to be sealed off. This may preferably be done by use of heat.
Finally the bag or the bag system is i:rozen to a tempera-ture below about -70 °C to make sure that the blood can be stored until the need for use thereof arises.
Various embodiments of the invention will be described below with reference to the drawings.
Fig. 1 illustrates a preferred embodiment of a bag ac-cording to the invention comprising a mixing chamber.
Fig. 2 illustrates a bag according to the invention adapted to be connected with a mixing bag.
Fig. 3 illustrates a bag in combination with a mixincJ bag according to tl~e invention.
5 Fig. 9 illustrates a bag system acct>rding to the inven-tion comprising a mixing chamber.
Fig. 5 illustrates another embodiment of storage chambers as a part of a bag system according to the invention.
Fig. 1 illustrates a bag according to tine invention com-prising a mixing chamber (1) with a double welding (S), w' and an inlet (11) equipped with a tube (3), which tube (3) at one end is equipped with a ~~onnector (4) to be connected with a needle for harvesting blood. Two snap locks (2) and (6) are placed at the inlet (11) and at the outlet (12) of the mixing chamber (1). The storage bag (13), which is connected with the mixing chamber (1) through a tube (14) equipped with a clamp (7), comprises o-ten primary storage chambers (8) and ten secondary stor-age chambers (9) in liquid communication with each other via pipe connections (10). The dottf=d lines show where the bag or the bag system is welded in order to seal off each chamber after the bag has been filled with blood.
When using a bag according to Fig. 1 the blood is led into the mixing chamber (1), where the above mentioned necessary agents are preferably already present, then the snap loch (2) is closed, and the bag is turned upside down or shaken iu order to mix the ingredients properly.
Then the snap lock (6) is opened and the blood mixture flows into the storage bag (13) filling up as many pri-mary (8) and secondary (9) storage chambers as possible.
To make sure that the blood mixture flows properly into the chambers, the person handling the bag can preferably squeeze or shal>e the bag a little to ease the flow of the blood mixture.
When all of the blood mixture contained in the mixing chamber (1) has flown into the storage bag (l.3), the clamp (7) is closed and the mixing chamber (1) is cut off. Then the pipe connections (10) are closed e.g. by welding, either shortly after the bag has been filled or at the latest just before the bag is frozen. The welding can be performed at the site, if the proper welding equipment is available or the bag can be placed at a tem-perature where substantially no bacteria can grow for up to 24 1-rours, and during that time be transported to a fa-cility at which the welding can be performed.
Fig. 1 illustrates a preferred embod-invent of a bag ac-cording to the invention wherein the mixing chamber con-stitutes part of the bag. In such a bag according to the invention, where the mixing chamber is included as a part of the bag, the risk of infection has been minimised, since there are no unnecessary contact with the surround-ings, such as transferring the blood from one bag to an-other, once tlne blood has been led into t1e bag. This bag also ensures that only a minimum of the blood is lost or destroyed during the process of collecting and storing the blood. In cases where the amount of blood obtained from the umbilical cord and the placenta is very small, this is particularly important.
As shown in F'ig . 1 the primary storage chambers and the pipe connections form a certain patteriu. However, this is merely one example of a pattern and many others may be appropriate, as e.g. shown in Figs. 2 and 3. The impor-tant aspect is that the pattern is designed to snake it possible to fill as many storage chambers as possible, even with only a small amount of blood available.
Fig. 2 shows a storage bag according to the invention with an opening for receiving blood (21) eauipped with a snap lock (22) and a clamp (23). 1'he bag comprises 12 primary storage chambers (24) and 7_2 secondary storage chambers (25) in liquid cormnunicatiori with each other via pipe connections (26). The dotted lines show where the bag is welded in order to seal off each chamber after the bag has been filled with blood.
This bag is adapted to be connected with a mixing bag, wherein the extracted blood is mixed with agents men- '--f boned above.
Fig. 3 shows a mixing bag (31) and a storage bag (35) ac cording to the invention. The mixing bag (31) consists of a mixing chamber (32) surrounded by a double welding (33) and is equipped with a connectcr (39) adapted to be con nected with the storage bag (35). The storage bag (35), o which is provided with an opening for receiving blood (36) equipped with a snap lock (37) and a clamp (28), comprises ten primary storage charnbe=rs (39) and ten sec-ondary storage chambers (40) in liquid corrununication with each other via pipe connections (41). The dotted lines show where the bag is welded in order to seal off each chamber after the bag has been filled with blood.
Fig. 9 shows a bag system according to tlae invention com-prising a mixing chamber (91) provided with means (51) for hanging the mixing chamber on a suitable stand or similar means, an opening for receiving and discharging blood (42) and a further port (43) for injection of addi-tives and/or extraction of blood for tests. The bag sys-tem further comprises 4 primary storage chambers (98) in liquid communication with each ether and the mixing cham-ber via pipe connectior_s (46) and connectors (95, 99) and for each primary storage chamber two secondary storage chambers (50). L,ach primary storage chamber may be sealed off from each other and from the mixing bag by using clamps (97).
When using a bag according to Figs. ~?, 3 and 9 the blood is led into a mixing bag and treated as described above, the difference being that the mixing chamber does not constitute part of the storage bag, but is provided as a separate bag. After the separate mixing bag has been con-nected to the storage bag, the blood flows into the pri-mary and secondary storage chambers as already described.
After the storage chambers have been filled the mixing bag is disconnected from the storage bag, and the storage bag is handled as explained above.
When using a bag system according to fig. 4 the primary and secondary storage chambers are preferably placed in a separate bag after being disconnected from the mixing chamber and optionally disconnected from the pipe connec tion by simply cutting them off. This bag may consist of one or more compartments each suitable for containing one ore more primary storage chambers and secondary storage chambers connected thereto. The compartments may be sepa rated by weldings.
In all four figures the secondary storage chambers have a substantial rectangular shape. However, this is only one example, and other shapes may be ~llst as appropriate.
Even though it appears from the figu=res that the primary and secondary storage chambers of a bag, respectively, have equal sizes and shapes, it should be understood that the sizes and shapes of the primary and secondary storage chambers of a bag, respectively, can differ from each other.
As shown in figs. 1 and 3 the mixing chamber is prefera-bly provided with a double welding, but other embodiments may be just as appropriate, e.g. a triple welding, or a double folio and a single welding.
Iin alternative embodiment of the storage chambers is shown in fig. 5, where the primary storage chamber (61) via a connector (63) is connected to the secondary stor-age chambers (65) which are sealed off from each other and the primary storage chamber by talurites (62) after being filled with blood. The clamp (69) is for sealing off the storage chamber from the pipe connection.
o-
This allows the blood to flow into the primary and secon-dary storage chambers, and after filling of as many cham-bers as possible with blood, the opening for receiving blood is closed, e.g. by use of a clamp er a snap lock.
Since there is no reed to store the attached empty mixing chamber, it is preferred to remove the mixing chamber, e.g. by cutting it of or removing the tubes and connec-tors that have been used.
o-In order to obtain a number of chambers that can be re-moved individually, the liquid conununication bet=ween the chambers has to be sealed off. This may preferably be done by use of heat.
Finally the bag or the bag system is i:rozen to a tempera-ture below about -70 °C to make sure that the blood can be stored until the need for use thereof arises.
Various embodiments of the invention will be described below with reference to the drawings.
Fig. 1 illustrates a preferred embodiment of a bag ac-cording to the invention comprising a mixing chamber.
Fig. 2 illustrates a bag according to the invention adapted to be connected with a mixing bag.
Fig. 3 illustrates a bag in combination with a mixincJ bag according to tl~e invention.
5 Fig. 9 illustrates a bag system acct>rding to the inven-tion comprising a mixing chamber.
Fig. 5 illustrates another embodiment of storage chambers as a part of a bag system according to the invention.
Fig. 1 illustrates a bag according to tine invention com-prising a mixing chamber (1) with a double welding (S), w' and an inlet (11) equipped with a tube (3), which tube (3) at one end is equipped with a ~~onnector (4) to be connected with a needle for harvesting blood. Two snap locks (2) and (6) are placed at the inlet (11) and at the outlet (12) of the mixing chamber (1). The storage bag (13), which is connected with the mixing chamber (1) through a tube (14) equipped with a clamp (7), comprises o-ten primary storage chambers (8) and ten secondary stor-age chambers (9) in liquid communication with each other via pipe connections (10). The dottf=d lines show where the bag or the bag system is welded in order to seal off each chamber after the bag has been filled with blood.
When using a bag according to Fig. 1 the blood is led into the mixing chamber (1), where the above mentioned necessary agents are preferably already present, then the snap loch (2) is closed, and the bag is turned upside down or shaken iu order to mix the ingredients properly.
Then the snap lock (6) is opened and the blood mixture flows into the storage bag (13) filling up as many pri-mary (8) and secondary (9) storage chambers as possible.
To make sure that the blood mixture flows properly into the chambers, the person handling the bag can preferably squeeze or shal>e the bag a little to ease the flow of the blood mixture.
When all of the blood mixture contained in the mixing chamber (1) has flown into the storage bag (l.3), the clamp (7) is closed and the mixing chamber (1) is cut off. Then the pipe connections (10) are closed e.g. by welding, either shortly after the bag has been filled or at the latest just before the bag is frozen. The welding can be performed at the site, if the proper welding equipment is available or the bag can be placed at a tem-perature where substantially no bacteria can grow for up to 24 1-rours, and during that time be transported to a fa-cility at which the welding can be performed.
Fig. 1 illustrates a preferred embod-invent of a bag ac-cording to the invention wherein the mixing chamber con-stitutes part of the bag. In such a bag according to the invention, where the mixing chamber is included as a part of the bag, the risk of infection has been minimised, since there are no unnecessary contact with the surround-ings, such as transferring the blood from one bag to an-other, once tlne blood has been led into t1e bag. This bag also ensures that only a minimum of the blood is lost or destroyed during the process of collecting and storing the blood. In cases where the amount of blood obtained from the umbilical cord and the placenta is very small, this is particularly important.
As shown in F'ig . 1 the primary storage chambers and the pipe connections form a certain patteriu. However, this is merely one example of a pattern and many others may be appropriate, as e.g. shown in Figs. 2 and 3. The impor-tant aspect is that the pattern is designed to snake it possible to fill as many storage chambers as possible, even with only a small amount of blood available.
Fig. 2 shows a storage bag according to the invention with an opening for receiving blood (21) eauipped with a snap lock (22) and a clamp (23). 1'he bag comprises 12 primary storage chambers (24) and 7_2 secondary storage chambers (25) in liquid cormnunicatiori with each other via pipe connections (26). The dotted lines show where the bag is welded in order to seal off each chamber after the bag has been filled with blood.
This bag is adapted to be connected with a mixing bag, wherein the extracted blood is mixed with agents men- '--f boned above.
Fig. 3 shows a mixing bag (31) and a storage bag (35) ac cording to the invention. The mixing bag (31) consists of a mixing chamber (32) surrounded by a double welding (33) and is equipped with a connectcr (39) adapted to be con nected with the storage bag (35). The storage bag (35), o which is provided with an opening for receiving blood (36) equipped with a snap lock (37) and a clamp (28), comprises ten primary storage charnbe=rs (39) and ten sec-ondary storage chambers (40) in liquid corrununication with each other via pipe connections (41). The dotted lines show where the bag is welded in order to seal off each chamber after the bag has been filled with blood.
Fig. 9 shows a bag system according to tlae invention com-prising a mixing chamber (91) provided with means (51) for hanging the mixing chamber on a suitable stand or similar means, an opening for receiving and discharging blood (42) and a further port (43) for injection of addi-tives and/or extraction of blood for tests. The bag sys-tem further comprises 4 primary storage chambers (98) in liquid communication with each ether and the mixing cham-ber via pipe connectior_s (46) and connectors (95, 99) and for each primary storage chamber two secondary storage chambers (50). L,ach primary storage chamber may be sealed off from each other and from the mixing bag by using clamps (97).
When using a bag according to Figs. ~?, 3 and 9 the blood is led into a mixing bag and treated as described above, the difference being that the mixing chamber does not constitute part of the storage bag, but is provided as a separate bag. After the separate mixing bag has been con-nected to the storage bag, the blood flows into the pri-mary and secondary storage chambers as already described.
After the storage chambers have been filled the mixing bag is disconnected from the storage bag, and the storage bag is handled as explained above.
When using a bag system according to fig. 4 the primary and secondary storage chambers are preferably placed in a separate bag after being disconnected from the mixing chamber and optionally disconnected from the pipe connec tion by simply cutting them off. This bag may consist of one or more compartments each suitable for containing one ore more primary storage chambers and secondary storage chambers connected thereto. The compartments may be sepa rated by weldings.
In all four figures the secondary storage chambers have a substantial rectangular shape. However, this is only one example, and other shapes may be ~llst as appropriate.
Even though it appears from the figu=res that the primary and secondary storage chambers of a bag, respectively, have equal sizes and shapes, it should be understood that the sizes and shapes of the primary and secondary storage chambers of a bag, respectively, can differ from each other.
As shown in figs. 1 and 3 the mixing chamber is prefera-bly provided with a double welding, but other embodiments may be just as appropriate, e.g. a triple welding, or a double folio and a single welding.
Iin alternative embodiment of the storage chambers is shown in fig. 5, where the primary storage chamber (61) via a connector (63) is connected to the secondary stor-age chambers (65) which are sealed off from each other and the primary storage chamber by talurites (62) after being filled with blood. The clamp (69) is for sealing off the storage chamber from the pipe connection.
o-
Claims (25)
1. A bag or a bag system for collecting and storing blood comprising an opening for receiving blood and at least two primary storage chambers and at least two secondary storage chambers, said primary storage chambers and said secondary storage chambers being in liquid communication with each other so that the blood can be filled through the opening and into both the primary and the secondary storage chambers and arranged in such a relation to each other so that each of the storage chambers can be sealed off from the others, wherein the volume of the primary storage chambers is larger than the volume of the secondary storage chambers.
2. A bag or a bag system according to claim 1, wherein the opening for receiving blood comprises an inlet channel.
3. A bag or a bag system for collecting and storing blood in combination with a mixing bag, said bag for collecting and storing blood being defined in claim 1, and wherein said mixing bag comprises at least one mixing chamber, an opening for receiving blood, and an opening for discharging blood, wherein said opening for discharging blood can be connected to the opening for receiving blood in the bag or the bag system for collecting and storing blood.
4. A bag or a bag system for collecting, mixing, and storing blood comprising an opening for receiving blood, and a mixing chamber, said mixing chamber being in liquid communication with at least two primary storage chambers and at least two secondary storage chambers, said primary storage chambers and said secondary storage chambers being in liquid communication with each other so that the blood can be filled through the opening and into both the primary and the secondary storage chamber, and arranged in such a relation to each other so that each of the storage chambers and the mixing chamber can be sealed off from the others by closing a snap lock or by using a clamp or by welding, wherein the volume of the primary storage chambers is larger than the volume of the secondary storage chambers.
5. A bag or a bag system according to claims 1-4, wherein said liquid communication is provided by pipe connections.
6. A bag or a bag system according to claim 5, wherein the pipe connections have a length in the range of 10-20 mm, preferably 12-15 mm.
7. A bag or a bag system according to claims 5-6, wherein the pipe connections have a length in the rage of 10-300 mm, preferably about 100 mm.
8. A bag or a bag system according to claims 5-7, wherein the pipe connections in a non collapsed condition have an inner diameter in the range of 2-10 mm. preferably 3-8 mm, more preferably 4-6 mm.
9. A bag or a bag system according to claims 3-8, wherein the mixing chamber is arranged in such a relation to the storage chambers so that it can be sealed off therefrom by closing a snap lock or by using a clamp or by welding and removed by cutting from the remaining bag before storage.
10. A bag or a bag system according to claims 1-9, wherein the primary storage chambers are marked individually, each primary storage chamber corresponding to at least one secondary storage chamber.
11. A bag or a bag system according to any of the preceding claims, wherein the bag or the bag system comprises at least 5 primary storage chambers, preferably at least 8 primary storage chambers, and more preferably at least primary storage chambers.
12. A bag or a bag system according to any of the preceding claims, wherein the ratio between the volumes of the primary and secondary storage chambers is between 40:1 and 60:1, preferably 50:1.
13. A bag or a bag system according to any of the preceding claims, wherein the ratio between the volumes of the primary and secondary storage chamber is in between 40:1 and 150:1, preferably between 50:1 and 80:1.
14. A bag or a bag system according to claims 3-13, wherein the volume of the mixing chamber is in the range of 100 to 500 ml, preferably 225 to 400 ml, more preferably 250 to 300 ml.
15. A bag or a bag system according to claims 3-14, wherein the volume of the mixing chamber is in the range of 100 to 500 ml, preferably 125 to 400 ml, more preferably 150 to 250 ml.
16. A bag or a bag system according to any of the preceding claims, wherein the volume of the primary storage chambers is in the range of 10 to 40 ml, preferably 25 to 35 ml, more preferably 25 to 30 ml.
17. A bag or a bag system according to claims 1-15, wherein the volume of the primary storage chambers is in the range of 10 to 30 ml, preferably 25 to 70 ml, more preferably 25 to 50 ml.
18. A bag or a bag system according to any of the preceding claims, wherein the volume of the secondary storage chambers is in the range of 0,2 to 1,5 ml, preferably 0,3 to 0,7 ml, more preferably 0,4 to 0,6 ml.
19. A bag or a bag system according to any of the preceding claims, wherein the shape of the primary storage chambers, when the bag or the bag system is in a collapsed condition, is substantially rectangular.
20. A bag or a bag system according to claims 1-18, wherein the shape of the primary storage chambers, when the bag or the bag system is in a collapsed condition, is substantially round.
21. A bag or a bag system according to claims 3-20, wherein the mixing chamber further comprises at least one port for injection of anticoagulation and/or preserving agents and/or for extracting blood for tests.
22. A bag or a bag system according to any of the preceding claims, wherein the bag or the bag system is made of a material of medical or pharmaceutical grade.
23. A bag or a bag system according to claim 22, wherein the material may be selected from a group comprising polyethylene, ethylene vinyl acetate copolymer, fluorine resin, polyimide silicone, an ABS polymer (acrylonitrile/butadien/styrene polymer or a polycarbonate.
24. A method for collecting and storing umbilical cord blood and/or blood from a placenta, comprising the steps of:
a) extracting blood from the umbilical cord and/or the placenta, b) leading it into a mixing chamber, e.g. by injection, c) mixing the blood with a preserving agent and/or an anticoagulation agent, d) optionally storing it for no longer than 24 hours, e) optionally adding further chemical to prepare the blood for cryo-preservation, f) providing a liquid communication between the mixing chamber and a number of storage chambers, allowing the blood mixture to flow into said storage chambers, g) closing the bag or the bag system with a clamp and optionally removing the mixing chamber, h) closing the channels between the various chambers e.g.
by welding or by closing a snap lock or a clamp, thereby providing a number of primary and secondary storage chambers sealed off from each other, and g) immediately placing the bag or the bag system in a freezer bringing the temperature below about -70 °C, wherein said primary and said secondary storage chambers are arranged in a storage bag or a bag system wherein the channels are linked to each other with intermediate seals, and the volume of the primary storage chambers is larger than the volume of the secondary storage chambers.
a) extracting blood from the umbilical cord and/or the placenta, b) leading it into a mixing chamber, e.g. by injection, c) mixing the blood with a preserving agent and/or an anticoagulation agent, d) optionally storing it for no longer than 24 hours, e) optionally adding further chemical to prepare the blood for cryo-preservation, f) providing a liquid communication between the mixing chamber and a number of storage chambers, allowing the blood mixture to flow into said storage chambers, g) closing the bag or the bag system with a clamp and optionally removing the mixing chamber, h) closing the channels between the various chambers e.g.
by welding or by closing a snap lock or a clamp, thereby providing a number of primary and secondary storage chambers sealed off from each other, and g) immediately placing the bag or the bag system in a freezer bringing the temperature below about -70 °C, wherein said primary and said secondary storage chambers are arranged in a storage bag or a bag system wherein the channels are linked to each other with intermediate seals, and the volume of the primary storage chambers is larger than the volume of the secondary storage chambers.
25. Method according to claim 24, wherein the bag or the bag system is according to any of the claims 1-23.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199800983 | 1998-07-29 | ||
DKPA199800983 | 1998-07-29 | ||
PCT/DK1999/000422 WO2000006079A1 (en) | 1998-07-29 | 1999-07-28 | A bag or a bag system for collecting and storing blood and a method therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2338604A1 true CA2338604A1 (en) | 2000-02-10 |
Family
ID=8099705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002338604A Abandoned CA2338604A1 (en) | 1998-07-29 | 1999-07-28 | A bag or a bag system for collecting and storing blood and a method therefor |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1100428A1 (en) |
JP (1) | JP2002521138A (en) |
CN (1) | CN1316895A (en) |
AU (1) | AU5027099A (en) |
BR (1) | BR9912546A (en) |
CA (1) | CA2338604A1 (en) |
HU (1) | HUP0103416A3 (en) |
ID (1) | ID30222A (en) |
NO (1) | NO20010440D0 (en) |
PL (1) | PL345797A1 (en) |
TW (1) | TW477696B (en) |
WO (1) | WO2000006079A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021015110A1 (en) * | 2019-07-22 | 2021-01-28 | Terumo Kabushiki Kaisha | Flow path device and biological component bag system |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8223647B2 (en) * | 2004-07-21 | 2012-07-17 | Nokia Corporation | System and method for increasing data throughout using a block acknowledgement |
WO2015120114A1 (en) | 2014-02-05 | 2015-08-13 | Muffin Incorporated | Compartmented cryopreservation container and uses thereof |
JP6230575B2 (en) * | 2015-08-11 | 2017-11-15 | 上田製袋株式会社 | Cryopreservation bag and method for enclosing living tissue in a cryopreservation bag |
DE102018103937A1 (en) * | 2018-02-21 | 2019-08-22 | Fresenius Medical Care Deutschland Gmbh | Device containing dialysis solution or dialysis solution concentrate |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4033345A (en) * | 1975-11-13 | 1977-07-05 | Sorenson Research Co., Inc. | Autologous transfusion filter system and method |
US5523004A (en) * | 1992-12-04 | 1996-06-04 | Terumo Kabushiki Kaisha | Method for treatment of blood using a blood bag |
SE510030C2 (en) * | 1995-08-08 | 1999-04-12 | Gambro Ab | Method of mixing sterile medical solution and container for carrying out the procedure |
DE19605357A1 (en) * | 1996-02-14 | 1997-08-21 | Braun Melsungen Ag | Flexible plastic container |
-
1999
- 1999-07-27 TW TW088112674A patent/TW477696B/en active
- 1999-07-28 JP JP2000561936A patent/JP2002521138A/en active Pending
- 1999-07-28 EP EP99934518A patent/EP1100428A1/en not_active Withdrawn
- 1999-07-28 PL PL99345797A patent/PL345797A1/en unknown
- 1999-07-28 CN CN99810655A patent/CN1316895A/en active Pending
- 1999-07-28 AU AU50270/99A patent/AU5027099A/en not_active Abandoned
- 1999-07-28 CA CA002338604A patent/CA2338604A1/en not_active Abandoned
- 1999-07-28 BR BR9912546-3A patent/BR9912546A/en not_active Application Discontinuation
- 1999-07-28 ID IDW20010371A patent/ID30222A/en unknown
- 1999-07-28 WO PCT/DK1999/000422 patent/WO2000006079A1/en not_active Application Discontinuation
- 1999-07-28 HU HU0103416A patent/HUP0103416A3/en unknown
-
2001
- 2001-01-25 NO NO20010440A patent/NO20010440D0/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021015110A1 (en) * | 2019-07-22 | 2021-01-28 | Terumo Kabushiki Kaisha | Flow path device and biological component bag system |
Also Published As
Publication number | Publication date |
---|---|
CN1316895A (en) | 2001-10-10 |
NO20010440L (en) | 2001-01-25 |
WO2000006079A1 (en) | 2000-02-10 |
NO20010440D0 (en) | 2001-01-25 |
TW477696B (en) | 2002-03-01 |
JP2002521138A (en) | 2002-07-16 |
ID30222A (en) | 2001-11-15 |
HUP0103416A3 (en) | 2002-04-29 |
BR9912546A (en) | 2001-05-02 |
EP1100428A1 (en) | 2001-05-23 |
AU5027099A (en) | 2000-02-21 |
PL345797A1 (en) | 2002-01-02 |
HUP0103416A2 (en) | 2002-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU780718B2 (en) | Blood processing set including an integrated blood sampling system | |
US7044941B2 (en) | Method and apparatus for collecting blood samples prior to a blood collection procedure | |
AU680994B2 (en) | Blood storage container and method of use | |
US4131200A (en) | Thermoplastic blood bag | |
EP0930079B1 (en) | Blood collecting apparatus | |
US7618584B2 (en) | Bag system for the cryopreservation of body fluids | |
CN101090666A (en) | Method and apparatus for blood sampling | |
EP2133086A1 (en) | Serum preparation method and serum preparation apparatus | |
BRPI0617028A2 (en) | cord and placenta fetal blood collection device, method of use, system for a closed-loop collection procedure and method of use of the system | |
CA2076677A1 (en) | Blood container having lay-flat sample reservoir | |
US7727219B2 (en) | Sterile system and methods for collecting, transporting, storing and cyropreserving body fluids | |
CA2338604A1 (en) | A bag or a bag system for collecting and storing blood and a method therefor | |
US20060167401A1 (en) | Apparatus and method for stem cell preservation and usage | |
WO2010122542A1 (en) | A container for storing a flowable bodily material, and a method for storing a flowable bodily material | |
US5564279A (en) | Freezing bags | |
JP2555452B2 (en) | Blood bag | |
US20140364833A1 (en) | Fetal blood recovery systems and methods | |
AU2005202959B2 (en) | Blood processing set including an integrated blood sampling system | |
PL225365B1 (en) | Umbilical cord blood collection kit | |
JPH03251252A (en) | Bag connecting body |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |